TABLE 3.
Phenotypic characterisation of antibiotic resistance profile of Escherichia coli isolates.
| Chemotherapeutic group | Chemotherapeutic agents/disc Potency μg/disc | No. of resistant strains |
||
|---|---|---|---|---|
| N | n | % | ||
| Aminoglycoside | Gentamycin (CN) (10 μg) | 94 | 9 | 9.6 |
| Streptomycin (S) (10 μg) | 94 | 78 | 83.0 | |
| Cephalosporins 4th generation | Cefepime (FEP) (30 μg) | 94 | 10 | 10.6 |
| Fluoroquinolones | Ciprofloxacin (CIP) (5 μg) | 94 | 12 | 12.8 |
| Danofloxacin (DAN) (5 μg) | 94 | 25 | 26.6 | |
| Other | Fosfomycin (FF) (50 μg) | 94 | 51 | 54.3 |
| Penicillins β-lactamase inhibitors | Piperacillin (PRL) (100 μg) | 94 | 83 | 88.3 |
| Penicillin (P) (10 μg) | 94 | 85 | 90.4 | |
| Amoxiclav (AMC) (30 μg) | 94 | 45 | 47.9 | |
| Chloramphenicol | Chloramphenicol (C) (30 μg) | 94 | 88 | 93.6 |
| Tetracycline | Tetracycline (T) (30 μg) | 94 | 90 | 95.7 |